Research

rs1047031 — DEFB1

3'UTR variant in the beta-defensin 1 gene that disrupts a microRNA binding site, reducing DEFB1 expression and increasing susceptibility to periodontitis and dental caries

Moderate Risk Factor Share

Details

Gene
DEFB1
Chromosome
8
Risk allele
T
Clinical
Risk Factor
Evidence
Moderate

Population Frequency

CC
71%
CT
27%
TT
3%

See your personal result for DEFB1

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

The Oral Defensin That Keeps Bacteria in Check — and What Happens When It Can't

Your mouth is never sterile. Billions of bacteria live on tooth surfaces, in the gingival sulcus, and throughout the oral cavity. What keeps them from overwhelming your gums and teeth is a first line of antimicrobial defense mounted by the epithelial cells lining the gums, tongue, and salivary glands — and one of the most important foot soldiers in that defense is human beta-defensin 1 (hBD-1)11 human beta-defensin 1 (hBD-1)
a small antimicrobial peptide secreted continuously by oral epithelial cells, part of the defensin family of innate immune proteins that punch holes in bacterial membranes
. Unlike some defensins that are induced only during infection, hBD-1 is constitutively expressed — it is always on duty.

The rs1047031 variant sits in the 3' untranslated region (3'UTR) of the DEFB1 gene, five nucleotides past the stop codon. On the genomic plus strand (GRCh38 chr8:6870676) this is a C→T transition. The DEFB1 gene is transcribed from the minus strand, so papers describe this as the c*5G>A variant — the "G" (coding strand) becoming an "A", corresponding to C→T on the plus strand. The T allele (rare allele, frequency ~17% in Europeans, ~4% in Africans, ~43% in East Asians) appears to disrupt a microRNA binding site in the 3'UTR, altering post-transcriptional regulation of DEFB1. Carriers of the TT genotype have the highest risk for periodontitis of any genotype at this locus.

The Mechanism

Messenger RNA is not translated into protein the moment it is made. The 3' untranslated region — the stretch of mRNA downstream of the protein-coding sequence — is a hub of post-transcriptional control. Small non-coding RNAs called microRNAs22 microRNAs
~22-nucleotide regulatory RNAs that bind complementary sequences in the 3'UTR and either block translation or trigger mRNA degradation, fine-tuning protein output without affecting the DNA sequence
bind sequences within the 3'UTR to fine-tune how much protein is made from a given transcript.

Computational analysis in the original Schaefer et al. study identified a predicted microRNA binding site exactly at the position of rs1047031. The T allele changes the sequence at this site, likely disrupting productive miRNA binding. Depending on whether the relevant miRNA is a positive (stabilizing) or negative (repressing) regulator of DEFB1, this disruption could either reduce or increase hBD-1 protein output. Given that the T allele is associated with increased susceptibility to periodontal pathogens, the most plausible interpretation is that the disrupted miRNA interaction leads to reduced or less stable hBD-1 expression in the oral epithelium — leaving fewer antimicrobial peptides to hold back periodontal bacteria.

A complementary line of evidence comes from studies of salivary hBD-1 levels: children with dental caries have significantly lower salivary hBD-1 than caries-free children33 significantly lower salivary hBD-1 than caries-free children
Lips et al., Caries Res 2017; n=678 Brazilian children; p<0.0001 for hBD-1 difference between caries cases and controls
, and a microRNA (miRNA202) variant that reduces hBD-1 levels was independently associated with higher caries risk. Together these findings support a model in which DEFB1 regulatory variants that reduce hBD-1 output increase susceptibility to both periodontal pathogens and cariogenic bacteria.

The Evidence

The primary association study by Schaefer et al. examined 1,337 periodontitis cases and 2,887 ethnically matched controls44 Schaefer et al. examined 1,337 periodontitis cases and 2,887 ethnically matched controls
Schaefer AS et al. A 3' UTR transition within DEFB1 is associated with chronic and aggressive periodontitis. Genes Immun. 2010 Jan;11(1):45-54
using a haplotype-tagging SNP approach across the DEFB1 locus. The 3'UTR rs1047031 emerged as the strongest signal: homozygous carriers of the rare allele (TT on the plus strand; AA in paper notation) had an odds ratio of 1.3 (95% CI 1.11–1.57, p=0.002) for periodontitis overall. Stratified analysis showed the effect was concentrated in chronic periodontitis (OR=2.2, 95% CI 1.16–4.35, p=0.02) and aggressive periodontitis (OR=1.3, 95% CI 1.04–1.68, p=0.02). Sequencing of the surrounding region identified no other associated variant, making rs1047031 the likely causative rather than merely tagging variant.

A meta-analysis of 13 publications55 meta-analysis of 13 publications
Ślebioda Z et al. Beta-defensin 1 gene polymorphisms in the pathologies of the oral cavity. J Oral Pathol Med. 2021
examining four DEFB1 polymorphisms across periodontitis, caries, lichen planus, and recurrent aphthous stomatitis found that rs1047031 was the only variant with a statistically significant pooled association with oral pathologies (adjusted p=0.003). The three 5'UTR promoter SNPs (rs1800972, rs1799946, rs11362) — sometimes studied separately for caries — did not reach significance in this broader meta-analysis, indicating rs1047031 has the strongest and most replicated signal across oral cavity conditions.

Evidence quality is moderate: the studies are case-control in design (no randomized intervention is feasible for a germline variant), effect sizes are modest (OR ~1.3–2.2), and the precise molecular mechanism (which miRNA, what direction of regulatory effect) remains to be experimentally confirmed.

Practical Actions

Reduced constitutive hBD-1 output means the innate antimicrobial barrier in the gingival sulcus is thinner than average. The bacteria that cause chronic periodontitis — particularly Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola — exploit reduced defensin levels to establish and maintain subgingival biofilm. Mechanical disruption of that biofilm through consistent interdental cleaning is the most evidence-based first response, because it removes the substrate before bacteria can cross the epithelial barrier.

Xylitol — a sugar alcohol that Streptococcus mutans cannot ferment — reduces the cariogenic bacterial load independently of your defensin levels, providing a complementary bacterial-load reduction strategy for caries susceptibility. Zinc ions at physiological concentrations have direct antimicrobial effects in the oral cavity and can partially compensate for reduced hBD-1 output; zinc-containing mouthwashes and toothpastes have documented efficacy against periodontal pathogens.

Professional monitoring matters here because biofilm control is not always achievable through home care alone in anatomically challenging sites (furcations, deep pockets). Detecting early bone loss before symptoms develop — when treatment is most effective — requires radiographic monitoring at appropriate intervals.

Interactions

The DEFB1 locus carries several independently studied polymorphisms. The three 5'UTR promoter variants — rs11362 (g.-20G>A), rs1800972 (g.-44C>G), and rs1799946 (g.-52G>A) — affect transcription factor binding and have been associated with altered hBD-1 expression and caries susceptibility in some studies. Combined genotype analysis across the locus (haplotypes spanning promoter and 3'UTR variants) may identify individuals with compound impairment of both transcriptional and post-transcriptional DEFB1 regulation. The 5'UTR SNPs are related but functionally distinct from rs1047031, which affects a different regulatory layer (miRNA-mediated post-transcriptional control vs. promoter-driven transcription initiation).

DEFB1 also interacts functionally with lactoferrin (LTF) in oral innate immunity: a study combining DEFB1 and LTF polymorphisms found combined associations with chronic periodontitis susceptibility, suggesting that individuals with reduced function in both the defensin and lactoferrin arms of oral innate immunity may face greater risk than variants in either gene alone.

Genotype Interpretations

What each possible genotype means for this variant:

CC “Standard Oral Defense” Normal

Common genotype — normal hBD-1 regulatory function

You have two copies of the C allele at this DEFB1 3'UTR position, the most common form globally (approximately 71% of people). The C allele maintains the intact microRNA binding site in the 3'UTR of DEFB1, supporting normal post-transcriptional regulation of human beta-defensin 1. Studies of rs1047031 and periodontitis risk find the CC genotype is not associated with elevated susceptibility to periodontal disease or dental caries at this locus. Your oral innate immune defense through the DEFB1 pathway is expected to function at typical levels.

CT “One Risk Copy” Intermediate Caution

One T allele — mildly elevated periodontitis susceptibility

You have one copy of the C allele and one copy of the T allele at this DEFB1 3'UTR position. About 27% of people carry this heterozygous genotype globally. The T allele disrupts a predicted microRNA binding site in the DEFB1 3'UTR and is associated with increased periodontitis risk when present in two copies (TT). With one T allele, the effect is expected to be intermediate — one normal C allele still contributes intact regulatory function. The additive inheritance pattern seen for rs1047031 means CT carriers are likely at modestly elevated risk compared to CC, though the primary published data characterize the TT homozygous effect most precisely.

TT “Elevated Periodontitis Risk” High Risk Warning

Two T alleles — strongest genetic signal for elevated periodontitis and oral infection susceptibility

Beta-defensin 1 is constitutively expressed in the oral epithelium — unlike cytokine-induced defensins, hBD-1 does not wait for infection to start. This constant low-level secretion into the gingival crevicular fluid acts as a tonic antimicrobial shield. When this constitutive output is reduced through post-transcriptional dysregulation at the rs1047031 site, the primary organisms that benefit are gram-negative anaerobes including Porphyromonas gingivalis and Treponema denticola — the keystone pathogens of chronic periodontitis. These species are already adapted to the subgingival anaerobic niche; reduced hBD-1 simply tilts the balance of the host-pathogen equilibrium in their favor.

The meta-analysis of 13 studies confirmed rs1047031 as the only DEFB1 SNP with a significant pooled signal across oral cavity pathologies (adjusted p=0.003), while three promoter-region SNPs that have been separately studied for caries susceptibility failed to reach significance at the meta-analytic level. This highlights the 3'UTR regulatory variant as the most broadly replicated signal in the gene.

Caries susceptibility may also be elevated: salivary hBD-1 levels are significantly lower in children with dental caries compared to caries-free controls, and hBD-1 has documented activity against Streptococcus mutans. Genetically reduced hBD-1 output could therefore contribute to cariogenic bacterial persistence alongside the established periodontitis risk.